Available HIV treatments are unsatisfactory since they don’t clear the infection and result in expensive and life?long treatment on an every?day basis. My research team use different systems virology approaches to combine clinical, experimental and bioinformatics research to explain how virus?host interactions regulate disease progression. My research is therefore often based on large-scale and multifaceted (often longitudinally) data that require advanced biostatistics and modeling. To functionally evaluate key markers and regulators of disease progression and their potential as treatment or vaccine targets, my team uses different human cell and tissue model systems.
